The SARS-CoV-2 pandemic has raised particular concern for people with Multiple Sclerosis,
as these people are believed to be at increased risk of infection, especially those being …

The purpose of this literature review was to summarise relevant findings regarding the
clinical management of multiple sclerosis (MS) in the COVID-19 pandemic, with the focus on …

Background: The SARS-CoV-2 pandemic represents one of the most challenging issues that
have recently influenced everyday life in countries all over the world. Understanding the risk …

The COVID-19 pandemic poses an ongoing global challenge, and several risk factors make
people with multiple sclerosis (pwMS) particularly susceptible to running a severe disease …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus,
emerged in December 2019, sparking a global health crisis. While initially recognized as a …

Objective The outbreak of the SARS‐CoV‐2 pandemic, caused by a previously unknown
infectious agent, posed unprecedented challenges to healthcare systems and unmasked …

Objective The purpose of this study was to investigate the effect of disease modifying
therapies on immune response to severe acute respiratory syndrome‐coronavirus 2 (SARS …

Abstract On 11 March 2020, the World Health Organization declared the coronavirus
disease 19 (COVID-19) outbreak a pandemic. In this context, several studies and clinical …

Background and purpose Information regarding multiple sclerosis (MS) patients with the
2019 novel coronavirus disease (COVID‐19) is scarce. The study objective was to describe …

During the COVID-19 pandemic, people with multiple sclerosis (MS) and their healthcare
providers have faced unique challenges related to the interaction between SARS-CoV-2 …